You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Toll-like receptor 8 (TLR8)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Pancreatic Adenocarcinoma, Refractory Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +2 more
  • Nivolumab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Dec 16, 2021

Testicular Torsion and TLR 4 Was Investigated Trial (Toll-like receptor 4)

Completed
  • Testicular Torsion and TLR 4 Was Investigated
  • Toll-like receptor 4
  • (no location specified)
Sep 23, 2022

Spondylitis, Tuberculosis Trial in Makassar (400 IU, 5000 IU, 10000 IU)

Not yet recruiting
  • Spondylitis
  • Tuberculosis
  • 400 IU
  • +3 more
  • Makassar, South Sulawesi, Indonesia
    Wahidin Sudirohusodo General Hospital
May 11, 2022

Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])

Withdrawn
  • Hepatitis B
  • Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
  • Baltimore, Maryland
  • +1 more
Jul 19, 2022

Melanoma Trial in Houston (gp100, R848 gel, MAGE-3)

Completed
Has Results
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 20, 2021

Solid Tumor Trial in Buffalo (entolimod, pharmacological study, laboratory biomarker analysis)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer Trial in New York (Radiation, Imiquimod, Cyclophosphamide)

Completed
Has Results
  • Breast Cancer
  • +2 more
  • Radiation
  • +2 more
  • New York, New York
    New York University Medical Center
Oct 25, 2021

Among HIV-1-infected Individuals With Previous or Current

Recruiting
  • Covid19
  • +2 more
  • Immune response study
  • Madrid, Spain
    Hospital Ramon y Cajal
Oct 23, 2021

Associated With Necrotizing Enterocolitis

Unknown status
  • Neonatal Disease
  • Gene expression of inflammatory mediator (Interleukin 8) and recognition receptor of Toll like receptor (TLR4).
  • (no location specified)
Sep 10, 2019

Cancer, Tumors Trial in Berlin (GSK1795091, Placebo)

Completed
Has Results
  • Cancer
  • Neoplasms
  • Berlin, Germany
    GSK Investigational Site
Nov 13, 2020

HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

Not yet recruiting
  • HIV-1-infection
  • ChAdOx1.tHIVconsv1
  • +7 more
  • San Diego, California
  • +11 more
Oct 4, 2023

Ovarian Cancer Trial in Switzerland, United States (Durvalumab, Pegylated Liposomal Doxorubicin, Motolimod)

Completed
Has Results
  • Ovarian Cancer
  • Phoenix, Arizona
  • +4 more
Aug 9, 2021

HIV Trial in Tygerberg Hills (HIVIS DNA/MVA-CMDR, HIVIS DNA + Cervarix and MVA-CMDR, Cervarix)

Recruiting
  • HIV Infections
  • HIVIS DNA/MVA-CMDR
  • +2 more
  • Tygerberg Hills, Cape Town, South Africa
    Stellenbosch University
Apr 20, 2022

Hepatitis B, HIV Trial in Worldwide (Selgantolimod, Placebo)

Recruiting
  • Hepatitis B
  • HIV Infections
  • San Diego, California
  • +35 more
Jan 31, 2023

Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon TLR7/8

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • Duarte, California
  • +12 more
Sep 21, 2022

Ewing Sarcoma, Rhabdomyosarcoma, Synovial Sarcoma Trial in Frankfurt am Main, Freiburg, Tübingen (Peptide vaccine IPX)

Recruiting
  • Ewing Sarcoma
  • +2 more
  • Peptide vaccine IPX
  • Frankfurt am Main, Germany
  • +2 more
Oct 18, 2023

Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Durvalumab
  • Rintatolimod
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Jun 23, 2023

Bladder Cancer Trial in Korea, Republic of, Poland, United States (PF-07225570, sasanlimab)

Recruiting
  • Bladder Cancer
  • New York, New York
  • +5 more
Jun 28, 2022

Metastatic Breast Cancer Trial (BDC-1001, Pertuzumab)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Jul 12, 2023

Serum Lactate and Ulcerative Colitis

Recruiting
  • Ulcerative Colitis
  • serum lactate
  • Assiut, Egypt
    Ahmed Mohammed Abu-Elfatth
May 24, 2023

Immune Cell Response to Stimuli

Recruiting
  • Inflammation
    • Research Triangle Park, North Carolina
      NIEHS Clinical Research Unit (CRU)
    Jan 25, 2023

    ASO and Beta-hemolytic Group A Streptococcus Infections in

    Unknown status
    • Attention Deficit-Hyperactivity Disorder
    • Antistreptolysin O Test
    • +3 more
    • Orbassano, Torino, Italy
      AOU San Luigi Gonzaga di Orbassano
    Mar 23, 2020

    SNPs in p53 and p53 Response Elements on Inflammatory Response

    Completed
    • HIV-1 Seropositive
    • +3 more
      • Research Triangle Park, North Carolina
        NIEHS Clinical Research Unit (CRU)
      Jan 21, 2023

      Periodontal Inflammation Trial in Ajman (saliva analysis for Toll like receptor activity)

      Completed
      • Periodontal Inflammation
      • saliva analysis for Toll like receptor activity
      • Ajman, Dubai, United Arab Emirates
        Ajman University
      Dec 16, 2019

      TLR4 Polymorphisms and Risk of Skin Cancer

      Active, not recruiting
      • Skin Cancer
      • Detection of single nucleotide polymorphisms (SNP)
      • Birmingham, Alabama
        The Kirklin Clinic
      Jan 20, 2022